Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Utah Medical ProductsUTMD +0.41%73 PS Ratio is 6.27 as of Aug. 27, 2026, which is 5% below its 10-year median of 6.63. GuruFocus rates UTMD with a GF Score™ of 73/100 and a GF Value™ of $57.89 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Utah Medical Products ranks worse than 74.5% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Utah Medical Products's share price is $70.84.
Utah Medical Products's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $11.31. Hence, Utah Medical Products's PS Ratio for today is 6.27.
Warning Sign:
Utah Medical Products Inc stock PS Ratio (=6.25) is close to 3-year high of 6.44.
The historical rank and industry rank for Utah Medical Products's PS Ratio or its related term are showing as below:
UTMD'
s PS Ratio Range Over the Past 10 Years
Min: 4.56 Med: 6.63 Max: 10.21
Current: 6.26
During the past 13 years, Utah Medical Products's highest PS Ratio was 10.21. The lowest was 4.56. And the median was 6.63.
UTMD's PS Ratio is ranked worse than 74.5% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.995
vs UTMD: 6.26
Utah Medical Products Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Utah Medical Products was -2.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -6.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -0.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 2.00% per year.
During the past 13 years, Utah Medical Products's highest 3-Year average Revenue per Share Growth Rate was 39.30% per year. The lowest was -8.80% per year. And the median was 6.30% per year.
Utah Medical Products (NAS:UTMD) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Utah Medical Products's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Utah Medical Products PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's PS Ratio distribution charts can be found below:
* The bar in red indicates where Utah Medical Products's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Utah Medical Products's Share Price of today is $70.84. Utah Medical Products's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.31.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Utah Medical Products (UTMD) has a PS Ratio of 6.27 as of Aug. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Utah Medical Products and its competitors. This is near median its historical median of 6.63. Over the past decade, Utah Medical Products' PS Ratio has ranged from 4.56 to 10.21. According to the industry distribution chart, Utah Medical Products ranks #599 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 74.5%.
Is Utah Medical Products' PS Ratio too high?
Utah Medical Products' current PS Ratio of 6.27 is near median its 10-year median of 6.63. Over the past 10 years, this metric has ranged from a low of 4.56 to a high of 10.21. The Medical Devices & Instruments industry median PS Ratio is 3.00. Utah Medical Products' value of 6.27 is 109.3% above this industry median. Based on the distribution chart, Utah Medical Products ranks #599 out of 804 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Utah Medical Products has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Utah Medical Products' PS Ratio compare to EMBC and SMTI?
According to the Medical Devices & Instruments industry distribution chart, Utah Medical Products ranks #599 out of 804 companies for PS Ratio. This places Utah Medical Products in the lower half of its industry. The industry median PS Ratio is 3.00. Utah Medical Products' value of 6.27 is 109.3% above this benchmark. Historically, Utah Medical Products' own PS Ratio has ranged from 4.56 to 10.21 over the past decade. While the company's 10-year median is 6.63 vs. the industry median of 3.00, Utah Medical Products has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 3.00, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Utah Medical Products's current PS Ratio of 6.27 is 109.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Utah Medical Products and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Utah Medical Products's current PS Ratio is 6.27, which is near median its own 10-year median of 6.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Utah Medical Products stock overvalued right now?
Based on GuruFocus' analysis, Utah Medical Products (UTMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $57.89, compared to a current price of $70.84 — trading 22.4% above its estimated fair value. The current PS Ratio is 6.27, which is near median its 10-year median of 6.63 and 109.3% above the Medical Devices & Instruments industry median of 3.00. Utah Medical Products' overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Utah Medical Products (UTMD), the current PS Ratio is 6.27 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Utah Medical Products (UTMD) Overvalued in 2026?
Based on GuruFocus' analysis, Utah Medical Products stock appears to be overvalued.
The current stock price of $70.84 is trading 22.4% above its estimated GF Value™ of $57.89.
GuruFocus considers Utah Medical Products to be Modestly Overvalued.
Key valuation signals for UTMD:
PS Ratio: 6.27 (near median its 10-year median of 6.63)
GF Value™: $57.89 vs. price of $70.84 (22.4% above fair value)
Industry Position: 109.3% above the Medical Devices & Instruments median (#599 of 804)
No single metric tells the full story. See the UTMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
73GF Score
Get the complete analysis for UTMD
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UTMD has been successfully added to your 
